tiprankstipranks
Trending News
More News >
Heron Therapeutics (HRTX)
NASDAQ:HRTX

Heron Therapeutics (HRTX) Revenue

Compare
1,634 Followers

Heron Therapeutics Revenue

Heron Therapeutics had a revenue of 40.59M in the quarter ending Dec 31, 2025, with 6.22%. This bring the company's revenue in the last twelve months to 154.90M, Increased -0.12%. In the fiscal year ending Dec 31, 2025, Heron Therapeutics had annual revenue of 154.90M with 7.36% growth.
Revenue (ttm)
154.90M
Revenue Growth
12.60%
P/S Ratio
1.02
Revenue/Employee
$1,269,705
Employees
122
Market Cap
$158.37M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
154.90M10.62M+7.36%
Dec 31, 2024
144.28M17.24M+13.57%
Dec 31, 2023
127.04M19.37M+17.99%
Dec 31, 2022
107.67M21.33M+24.70%
Dec 31, 2021
86.35M-2.29M-2.59%
Dec 31, 2020
88.64M-57.33M-39.28%
Dec 31, 2019
145.97M68.49M+88.41%
Dec 31, 2018
77.47M46.71M+151.81%
Dec 31, 2017
30.77M